Recordati Industria Chimica e Farmaceutica S.p.A.

BIT:REC Lagerbericht

Marktkapitalisierung: €10.5b

Recordati Industria Chimica e Farmaceutica Management

Management Kriterienprüfungen 4/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Rob Koremans

Geschäftsführender

€2.5m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts23.6%
Amtszeit als Geschäftsführer2.9yrs
Eigentum des Geschäftsführersn/a
Durchschnittliche Amtszeit des Managements4.2yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder5.2yrs

Jüngste Management Updates

Recent updates

We Like The Quality Of Recordati Industria Chimica e Farmaceutica's (BIT:REC) Earnings

Nov 18
We Like The Quality Of Recordati Industria Chimica e Farmaceutica's (BIT:REC) Earnings

Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Due To Pay A Dividend Of €0.60

Nov 14
Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Due To Pay A Dividend Of €0.60

Earnings Beat: Recordati Industria Chimica e Farmaceutica S.p.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Nov 13
Earnings Beat: Recordati Industria Chimica e Farmaceutica S.p.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Not Flying Under The Radar

Oct 31
Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Not Flying Under The Radar

Estimating The Fair Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Sep 07
Estimating The Fair Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

We Think Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Stay On Top Of Its Debt

Aug 20
We Think Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Stay On Top Of Its Debt

Earnings Miss: Recordati Industria Chimica e Farmaceutica S.p.A. Missed EPS By 31% And Analysts Are Revising Their Forecasts

Aug 02
Earnings Miss: Recordati Industria Chimica e Farmaceutica S.p.A. Missed EPS By 31% And Analysts Are Revising Their Forecasts

Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Business Is Yet to Catch Up With Its Share Price

Aug 01
Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Business Is Yet to Catch Up With Its Share Price

Estimating The Intrinsic Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

May 26
Estimating The Intrinsic Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Recordati Industria Chimica e Farmaceutica (BIT:REC) Will Pay A Larger Dividend Than Last Year At €0.63

May 10
Recordati Industria Chimica e Farmaceutica (BIT:REC) Will Pay A Larger Dividend Than Last Year At €0.63

Recordati Industria Chimica e Farmaceutica's (BIT:REC) Dividend Will Be Increased To €0.63

Apr 25
Recordati Industria Chimica e Farmaceutica's (BIT:REC) Dividend Will Be Increased To €0.63

Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Share Price Could Signal Some Risk

Apr 23
Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Share Price Could Signal Some Risk

If EPS Growth Is Important To You, Recordati Industria Chimica e Farmaceutica (BIT:REC) Presents An Opportunity

Apr 08
If EPS Growth Is Important To You, Recordati Industria Chimica e Farmaceutica (BIT:REC) Presents An Opportunity

Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Increasing Its Dividend To €0.63

Mar 23
Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Increasing Its Dividend To €0.63

Is Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Expensive For A Reason? A Look At Its Intrinsic Value

Jan 27
Is Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Expensive For A Reason? A Look At Its Intrinsic Value

We Think Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Stay On Top Of Its Debt

Jan 09
We Think Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Stay On Top Of Its Debt

Risks To Shareholder Returns Are Elevated At These Prices For Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Dec 22
Risks To Shareholder Returns Are Elevated At These Prices For Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Recordati Industria Chimica e Farmaceutica (BIT:REC) Has Announced That It Will Be Increasing Its Dividend To €0.57

Nov 12
Recordati Industria Chimica e Farmaceutica (BIT:REC) Has Announced That It Will Be Increasing Its Dividend To €0.57

Is Recordati Industria Chimica e Farmaceutica (BIT:REC) Using Too Much Debt?

Sep 29
Is Recordati Industria Chimica e Farmaceutica (BIT:REC) Using Too Much Debt?

Estimating The Fair Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Sep 08
Estimating The Fair Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Here's Why Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Manage Its Debt Responsibly

Jun 23
Here's Why Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Manage Its Debt Responsibly

Does This Valuation Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Imply Investors Are Overpaying?

Jun 05
Does This Valuation Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Imply Investors Are Overpaying?

Recordati Industria Chimica e Farmaceutica's (BIT:REC) Conservative Accounting Might Explain Soft Earnings

Apr 08
Recordati Industria Chimica e Farmaceutica's (BIT:REC) Conservative Accounting Might Explain Soft Earnings

Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Increasing Its Dividend To €0.60

Apr 05
Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Increasing Its Dividend To €0.60

Recordati Industria Chimica e Farmaceutica (BIT:REC) Has Announced That It Will Be Increasing Its Dividend To €0.60

Mar 19
Recordati Industria Chimica e Farmaceutica (BIT:REC) Has Announced That It Will Be Increasing Its Dividend To €0.60

Here's Why Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Manage Its Debt Responsibly

Mar 06
Here's Why Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Manage Its Debt Responsibly

A Look At The Intrinsic Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Dec 23
A Look At The Intrinsic Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Is Recordati Industria Chimica e Farmaceutica (BIT:REC) A Risky Investment?

Dec 05
Is Recordati Industria Chimica e Farmaceutica (BIT:REC) A Risky Investment?

Recordati Industria Chimica e Farmaceutica (BIT:REC) Will Pay A Larger Dividend Than Last Year At €0.55

Nov 11
Recordati Industria Chimica e Farmaceutica (BIT:REC) Will Pay A Larger Dividend Than Last Year At €0.55

Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Intrinsic Value Is Potentially 42% Above Its Share Price

Sep 01
Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Intrinsic Value Is Potentially 42% Above Its Share Price

These 4 Measures Indicate That Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Using Debt Reasonably Well

Aug 07
These 4 Measures Indicate That Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Using Debt Reasonably Well

An Intrinsic Calculation For Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Suggests It's 25% Undervalued

Jun 03
An Intrinsic Calculation For Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Suggests It's 25% Undervalued

Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Paying Out A Larger Dividend Than Last Year

May 16
Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Paying Out A Larger Dividend Than Last Year

Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Paying Out A Larger Dividend Than Last Year

May 02
Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Paying Out A Larger Dividend Than Last Year

Recordati Industria Chimica e Farmaceutica's (BIT:REC) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 18
Recordati Industria Chimica e Farmaceutica's (BIT:REC) Shareholders Will Receive A Bigger Dividend Than Last Year

Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Increasing Its Dividend To €0.57

Apr 04
Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Increasing Its Dividend To €0.57

Recordati Industria Chimica e Farmaceutica (BIT:REC) Will Pay A Larger Dividend Than Last Year At €0.57

Mar 21
Recordati Industria Chimica e Farmaceutica (BIT:REC) Will Pay A Larger Dividend Than Last Year At €0.57

These 4 Measures Indicate That Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Using Debt Reasonably Well

Mar 06
These 4 Measures Indicate That Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Using Debt Reasonably Well

Calculating The Intrinsic Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Dec 22
Calculating The Intrinsic Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Recordati Industria Chimica e Farmaceutica (BIT:REC) Has A Pretty Healthy Balance Sheet

Dec 05
Recordati Industria Chimica e Farmaceutica (BIT:REC) Has A Pretty Healthy Balance Sheet

Estimating The Intrinsic Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Sep 23
Estimating The Intrinsic Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Is Recordati Industria Chimica e Farmaceutica (BIT:REC) A Risky Investment?

Sep 05
Is Recordati Industria Chimica e Farmaceutica (BIT:REC) A Risky Investment?

A Look At The Fair Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Jun 25
A Look At The Fair Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Here's Why Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Manage Its Debt Responsibly

Jun 07
Here's Why Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Manage Its Debt Responsibly

Earnings Miss: Recordati Industria Chimica e Farmaceutica S.p.A. Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

May 10
Earnings Miss: Recordati Industria Chimica e Farmaceutica S.p.A. Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Shares Could Be 34% Above Their Intrinsic Value Estimate

Mar 11
Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Shares Could Be 34% Above Their Intrinsic Value Estimate

Here's What You Should Know About Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) 2.4% Dividend Yield

Feb 19
Here's What You Should Know About Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) 2.4% Dividend Yield

Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Jan 30
Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Rob Koremans im Vergleich zu den Einnahmen von Recordati Industria Chimica e Farmaceutica verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Sep 30 2024n/an/a

€423m

Jun 30 2024n/an/a

€387m

Mar 31 2024n/an/a

€389m

Dec 31 2023€2m€590k

€389m

Sep 30 2023n/an/a

€375m

Jun 30 2023n/an/a

€389m

Mar 31 2023n/an/a

€340m

Dec 31 2022€2m€590k

€312m

Sep 30 2022n/an/a

€331m

Jun 30 2022n/an/a

€330m

Mar 31 2022n/an/a

€393m

Dec 31 2021€154kn/a

€386m

Vergütung im Vergleich zum Markt: RobDie Gesamtvergütung ($USD2.63M) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt Italian ($USD3.24M).

Entschädigung vs. Einkommen: RobDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Rob Koremans (62 yo)

2.9yrs

Amtszeit

€2,498,000

Vergütung

Dr. Robert Koremans, also known as Rob, M.D. serves as Chief Executive Officer and Director of Recordati Industria Chimica e Farmaceutica S.p.A. since December 1, 2021. Dr. Koremans served as Chief Executi...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Robert Koremans
CEO & Director2.9yrs€2.50mkeine Daten
Luigi Felice Corte
Group CFO & Executive Director5yrs€1.23mkeine Daten
Cathrin Petty
Executive Directorno datakeine Datenkeine Daten
Giampiero Mazza
Executive Director5.8yrskeine Datenkeine Daten
Giorgio De Palma
Executive Director4.6yrskeine Datenkeine Daten
Eugenia Litz
VP & Head of Investor Relationsless than a yearkeine Datenkeine Daten
Bibianne Bon
Group Chief Legal Officer1.6yrskeine Datenkeine Daten
Laura Conti
Group Communications Directorno datakeine Datenkeine Daten
Gabriele Finzi
Executive VP of Corporate Development8.2yrskeine Datenkeine Daten
Alessandra Abate
Group Chief People & Culture Officerless than a yearkeine Datenkeine Daten
Raffaele Sabia
Chief Medical Officer5.8yrskeine Datenkeine Daten
Alberto Martinez
Executive Vice President of Specialty & Primary Care Business Unit3.8yrskeine Datenkeine Daten

4.2yrs

Durchschnittliche Betriebszugehörigkeit

55yo

Durchschnittliches Alter

Erfahrenes Management: RECDas Führungsteam des Unternehmens gilt als erfahren (4.2 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Robert Koremans
CEO & Director2.9yrs€2.50mkeine Daten
Luigi Felice Corte
Group CFO & Executive Director2.8yrs€1.23mkeine Daten
Cathrin Petty
Executive Director5.9yrskeine Datenkeine Daten
Giampiero Mazza
Executive Director5.9yrskeine Datenkeine Daten
Giorgio De Palma
Executive Director4.6yrskeine Datenkeine Daten
Andrea Recordati
Non-Executive Chairman26.6yrs€315.00kkeine Daten
Piergiorgio Peluso
Independent Non-Executive Director4.6yrs€80.00kkeine Daten
Michaela Castelli
Lead Independent Director10.6yrs€103.00kkeine Daten
Elisa Corghi
Independent Director2.8yrs€90.00kkeine Daten
Antonio Santi
Chairman of Statutory Auditor Board7.6yrskeine Datenkeine Daten
Joanna Le Couilliard
Independent Non-Executive Director5.8yrs€85.00kkeine Daten
Guido Guidi
Non-Executive Vice Chairman4.6yrs€90.00kkeine Daten

5.2yrs

Durchschnittliche Betriebszugehörigkeit

54.5yo

Durchschnittliches Alter

Erfahrener Vorstand: RECDie Vorstandsmitglieder gelten als erfahren (5.2 Jahre durchschnittliche Amtszeit).